Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Jail-to-community treatment continuum for adults with co-occurring substance use and mental disorders: study protocol for a pilot randomized controlled trial.

Van Dorn RA, Desmarais SL, Rade CB, Burris EN, Cuddeback GS, Johnson KL, Tueller SJ, Comfort ML, Mueser KT.

Trials. 2017 Aug 4;18(1):365. doi: 10.1186/s13063-017-2088-z.

2.

A Hybrid III stepped wedge cluster randomized trial testing an implementation strategy to facilitate the use of an evidence-based practice in VA Homeless Primary Care Treatment Programs.

Simmons MM, Gabrielian S, Byrne T, McCullough MB, Smith JL, Taylor TJ, O'Toole TP, Kane V, Yakovchenko V, McInnes DK, Smelson DA.

Implement Sci. 2017 Apr 4;12(1):46. doi: 10.1186/s13012-017-0563-2.

3.

Professionals' perception on the management of patients with dual disorders.

Roncero C, Szerman N, Terán A, Pino C, Vázquez JM, Velasco E, García-Dorado M, Casas M.

Patient Prefer Adherence. 2016 Sep 19;10:1855-1868. eCollection 2016.

4.

A cluster randomized Hybrid Type III trial testing an implementation support strategy to facilitate the use of an evidence-based practice in VA homeless programs.

Smelson DA, Chinman M, McCarthy S, Hannah G, Sawh L, Glickman M.

Implement Sci. 2015 May 28;10:79. doi: 10.1186/s13012-015-0267-4.

5.

Dual recovery among people with serious mental illnesses and substance problems: a qualitative analysis.

Green CA, Yarborough MT, Polen MR, Janoff SL, Yarborough BJ.

J Dual Diagn. 2015;11(1):33-41. doi: 10.1080/15504263.2014.975004. Epub 2014 Dec 9.

6.

Cigarette Smoking and Health Characteristics in Individuals With Serious Mental Illness Enrolled in a Behavioral Weight Loss Trial.

Dickerson FB, Yu A, Dalcin A, Jerome GJ, Gennusa JV 3rd, Charleston J, Crum RM, Campbell L, Oefinger M, Appel LJ, Daumit GL.

J Dual Diagn. 2013 Jan 1;9(1):39-46.

7.

Implementing Residential Integrated Treatment for Co-occurring Disorders.

McKee SA, Harris GT, Cormier CA.

J Dual Diagn. 2013 Jul;9(3):249-259.

8.

Bipolar disorder and alcohol use disorder: a review.

Farren CK, Hill KP, Weiss RD.

Curr Psychiatry Rep. 2012 Dec;14(6):659-66. doi: 10.1007/s11920-012-0320-9. Review.

9.

Physical Health and Dual Diagnosis.

Robson D, Keen S, Mauro P.

Adv Dual Diagn. 2008;1(1):27-32.

10.

Evolution of Substance use, Neurological and Psychiatric Symptoms in Schizophrenia and Substance use Disorder Patients: A 12-Week, Pilot, Case-Control Trial with Quetiapine.

Zhornitsky S, Stip E, Desfossés J, Pampoulova T, Rizkallah E, Rompré PP, Bentaleb LA, Lipp O, Chiasson JP, Gendron A, Potvin S.

Front Psychiatry. 2011 May 13;2:22. doi: 10.3389/fpsyt.2011.00022. eCollection 2011.

11.

The efficacy of assertive community treatment to treat substance use.

Fries HP, Rosen MI.

J Am Psychiatr Nurses Assoc. 2011 Jan-Feb;17(1):45-50. doi: 10.1177/1078390310393509. Review.

12.

Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial.

Barrowclough C, Haddock G, Wykes T, Beardmore R, Conrod P, Craig T, Davies L, Dunn G, Eisner E, Lewis S, Moring J, Steel C, Tarrier N.

BMJ. 2010 Nov 24;341:c6325. doi: 10.1136/bmj.c6325.

13.

Advisor-Teller Money Manager (ATM) therapy for substance use disorders.

Rosen MI, Rounsaville BJ, Ablondi K, Black AC, Rosenheck RA.

Psychiatr Serv. 2010 Jul;61(7):707-13. doi: 10.1176/ps.2010.61.7.707.

14.

Integrating services for patients with mental and substance use disorders: What matters?

Brousselle A, Lamothe L, Sylvain C, Foro A, Perreault M.

Health Care Manage Rev. 2010 Jul-Sep;35(3):212-23. doi: 10.1097/HMR.0b013e3181d5b11c.

15.

The impact of substance abuse on osteoporosis screening and risk of osteoporosis in women with psychotic disorders.

Kelly DL, Myers CS, Abrams MT, Feldman S, Park J, McMahon RP, Shim JC.

Osteoporos Int. 2011 Apr;22(4):1133-43. doi: 10.1007/s00198-010-1294-2. Epub 2010 Jun 9.

16.

Free-running rhythms of cocaine self-administration in rats held under constant lighting conditions.

Bass CE, Jansen HT, Roberts DC.

Chronobiol Int. 2010 May;27(3):535-48. doi: 10.3109/07420521003664221.

17.

Intrinsic motivation as a mediator of relationships between symptoms and functioning among individuals with schizophrenia spectrum disorders in a diverse urban community.

Yamada AM, Lee KK, Dinh TQ, Barrio C, Brekke JS.

J Nerv Ment Dis. 2010 Jan;198(1):28-34. doi: 10.1097/NMD.0b013e3181c8aa71.

18.

Cigarette smoking and mortality risk in people with schizophrenia.

Kelly DL, McMahon RP, Wehring HJ, Liu F, Mackowick KM, Boggs DL, Warren KR, Feldman S, Shim JC, Love RC, Dixon L.

Schizophr Bull. 2011 Jul;37(4):832-8. doi: 10.1093/schbul/sbp152. Epub 2009 Dec 17.

19.

A systematic review of the international published literature relating to quality of institutional care for people with longer term mental health problems.

Taylor TL, Killaspy H, Wright C, Turton P, White S, Kallert TW, Schuster M, Cervilla JA, Brangier P, Raboch J, Kalisová L, Onchev G, Dimitrov H, Mezzina R, Wolf K, Wiersma D, Visser E, Kiejna A, Piotrowski P, Ploumpidis D, Gonidakis F, Caldas-de-Almeida J, Cardoso G, King MB.

BMC Psychiatry. 2009 Sep 7;9:55. doi: 10.1186/1471-244X-9-55. Review.

20.

Supplemental Content

Support Center